Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 12, Issue 3, Pages 383-388Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2012.02.001
Keywords
-
Categories
Funding
- NIAMS NIH HHS [R01 AR053948-05, R01 AR053948] Funding Source: Medline
- NIGMS NIH HHS [T32 GM008136] Funding Source: Medline
Ask authors/readers for more resources
The genetics of skeletal muscle lineage commitment are deceptively complicated. MyoD overexpression is sufficient to convert fibroblasts into skeletal muscle myotubes. In vivo, there are a number of different steps of differentiation that require a large network of transcription factors that control differentiation and homeostasis of skeletal muscle progenitors. Each transcription factor has been shown to have the ability to promote the next factor in the cascade, but the mechanisms regulating the transitions remain incomplete. Recently, microRNAs have been shown to be important for a large number of developmental and oncogenic processes. In this review, we will discuss recent advances in the understanding of how microRNA is critical for skeletal muscle development by interacting with protein-coding genes that had previously been shown to be important for myogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available